Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Sequential and Hybrid Therapies for H Pylori Infection [Phase 4]
A Phase 4 clinical trial update on sequential and hybrid therapies for Helicobacter pylori infection. The study status is completed with res…
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication [Phase 4]
A Phase 4 trial comparing levofloxacin-based triple therapy to clarithromycin-based triple therapy as first-line treatments for Helicobacter…
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study [Phase 4]
A Phase 4 pilot study evaluating sequential therapy as a second-line treatment for patients with refractory Helicobacter pylori infection ha…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study [Phase 4]
A Phase 4 pilot trial in adults in El Paso, Texas is evaluating eradication of Helicobacter pylori using Pyklear; the study status is curren…
-
FDA approval · 2011-01-19FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride for the treatment of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE — Original Application (NorthStar RxLLC)
FDA approved the original application for pantoprazole submitted by NorthStar RxLLC, launching a generic pantoprazole product.
-
CLINICAL_TRIALS research · 2011-01-19Clinical Trial Update: The Effect of PPI Therapy on the Result of Helicobacter Pylori Diagnostic Tests
This clinical trial update examines whether proton pump inhibitor therapy affects the results of Helicobacter pylori diagnostic tests.
-
FDA approval · 2011-01-07FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc., granting an additional approval under the ANDA for the generic …
-
FDA approval · 2010-12-22FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for clarithromycin by Sandoz Inc., confirming the approval of a generic clarithromycin product under…
-
FDA approval · 2010-09-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc., representing a labeling amen…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy [Phase 3]
This Phase 3 trial compared quadruple therapy to triple therapy for eradicating Helicobacter pylori, reporting efficacy and safety results. …
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Mixed Strain H. Pylori Infection in Patients Who Have Problems With Eradication of H. Pylori
The clinical trial evaluating mixed-strain Helicobacter pylori infection in patients with eradication failure has completed.
-
FDA label_change · 2010-07-16FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a labeling supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen. The update m…
-
CLINICAL_TRIALS research · 2010-07-12Clinical Trial Update: The Role of Cathepsin X in Infection With the Helicobacter Pylori
This update covers a study examining the role of Cathepsin X in Helicobacter pylori infection. The current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. [Phase 4]
A Phase 4 clinical trial evaluated the safety and effectiveness of rabeprazole for treating Helicobacter pylori infection in adults; the stu…
-
FDA approval · 2010-03-04FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP. The approval update…
-
FDA approval · 2010-02-26FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
FDA Supplemental Application approval for IDKIT HP ONE, a 13C-urea citric acid breath test kit for detecting Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes
Update on a clinical trial investigating how dietary heme/non-heme iron and Helicobacter pylori infection affect maternal iron-deficiency an…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study [Phase 2]
Phase 2 pilot study assessing the efficacy of acetilcysteine as rescue therapy for Helicobacter pylori infection.
-
FDA approval · 2010-01-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application to update the labeling for Omeprazole and Sodium Bicarbonate (Oceanside Pharmaceuticals).
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: The Effect of Berry Extract on Helicobacter Pylori Eradication [Phase 1]
This Phase 1 clinical trial assesses whether berry extract increases the eradication rate of Helicobacter pylori.
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)
A completed pediatric clinical trial investigates risk factors for gastric disease associated with Helicobacter pylori infection, including …
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved an original ANDA for lansoprazole from Teva Pharmaceuticals USA, Inc., allowing a generic version of the proton pump inhibitor.…
-
CLINICAL_TRIALS trial_result · 2009-11-10Clinical Trial Update: Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms [NA]
The trial completed an assessment of whether eradicating Helicobacter pylori affects dyspeptic symptoms in patients with functional dyspepsi…
-
CLINICAL_TRIALS research · 2009-10-06Clinical Trial Update: Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of Helicobacter pylori eradication therapy in patients with functional dyspepsia…